GRAIL, Inc. Stock-Based Compensation
GRAIL, Inc. (GRAL) reported Stock-Based Compensation of $36.35 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- GRAIL, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $19.56M, a 38.04% increase year-over-year.
- GRAIL, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $16.79M, a 3.59% increase year-over-year.
- GRAIL, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $13.77M, a 1.35% increase year-over-year.
- GRAIL, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $14.14M, a 18.97% decline year-over-year.
- GRAIL, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $58.28M, a 32.30% decline from fiscal 2024.
- GRAIL, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $86.08M, a 11.47% decline from fiscal 2023.
- GRAIL, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $97.23M, a 28.40% increase from fiscal 2023.
- GRAIL, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $75.73M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $36.35M 10-Q · filed 2026-08-06 | $50.12M derived: sum of 3 quarters · filed 2026-08-06 | $64.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $16.79M 10-Q · filed 2026-05-07 | $30.56M derived: sum of 2 quarters · filed 2026-05-07 | $44.70M derived: sum of 3 quarters · filed 2026-05-07 | $58.87M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $13.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $27.90M derived: sum of 2 quarters · filed 2026-03-12 | $42.07M derived: sum of 3 quarters · filed 2026-08-06 | $58.28M 10-K · filed 2026-03-12 |
| 2025-09-30 | $14.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $28.31M derived: sum of 2 quarters · filed 2026-08-06 | $44.52M 10-Q · filed 2025-11-13 | $58.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $14.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $30.38M 10-Q · filed 2026-08-06 | $43.96M derived: sum of 3 quarters · filed 2026-08-06 | $61.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $16.21M 10-Q · filed 2026-05-07 | $29.79M derived: sum of 2 quarters · filed 2026-05-07 | $47.24M derived: sum of 3 quarters · filed 2026-05-07 | $73.19M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $13.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $31.03M derived: sum of 2 quarters · filed 2026-03-12 | $56.98M derived: sum of 3 quarters · filed 2026-03-12 | $86.08M 10-K · filed 2026-03-12 |
| 2024-09-30 | $17.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $43.40M derived: sum of 2 quarters · filed 2025-11-13 | $72.50M 10-Q · filed 2025-11-13 | $97.35M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-06-30 | $25.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $55.05M 10-Q · filed 2025-08-13 | $79.91M derived: sum of 3 quarters · filed 2026-03-12 | $105.22M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-03-31 | $29.11M 10-Q · filed 2025-05-14 | $53.96M derived: sum of 2 quarters · filed 2026-03-12 | $79.28M derived: sum of 3 quarters · filed 2026-03-12 | |
| 2023-12-31 | $24.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $50.17M derived: sum of 2 quarters · filed 2026-03-12 | $97.23M 10-K · filed 2025-03-05 | |
| 2023-10-01 | $25.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $72.38M 10-Q · filed 2024-11-13 | ||
| 2023-06-30 | $47.06M 10-Q · filed 2024-08-13 | |||
| 2023-01-01 | $75.73M 10-K · filed 2025-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |